Pathogenetic signaling pathways in age-related macular degeneration (AMD), Alzheimer's disease (AD) and prion disease (PrD) involve the participation of common pro-inflammatory, and innate-immune disrupting microRNAs that include miRNA-34a, miRNA-146a and miRNA-155.